Epidemic Group¹ publishes 2025 Annual and Sustainability Report: A transformative year investing significantly into AI and bringing the company back to profitable growth in 2026

Epidemic Group published its 2025 Annual and Sustainability Report, highlighting a shift toward an AI-first creative platform built on investments made during 2025. The company says operational work in 2025 is positioning it to broaden its strategy beyond music licensing and be “future-proof” for 2026. No financial metrics or guidance changes were provided in the excerpt, implying limited near-term market impact.

Analysis

This reads more like a capex/opex transition than an earnings catalyst. If the company is truly moving from narrow licensing into a broader creative workflow, the near-term trade-off is lower reported margin for a potentially stickier platform; the market usually gives limited credit until there is proof of net revenue retention, attach rates, and lower churn. The biggest upside is not in the annual report itself but in whether AI reduces content production cost enough to expand gross margins without accelerating customer price erosion.

Competitive dynamics matter more than the sustainability framing. A successful AI-first product can pressure legacy stock-content and licensing models by bundling creation, editing, and distribution into one workflow, which is negative for incumbents like SSTK and GETY if buyers substitute away from fragmented content purchases. But the same move can also commoditize the core asset faster: if AI-generated assets become table stakes, pricing power migrates to the workflow layer, not the underlying library.

The contrarian risk is that this is mostly narrative ahead of measurable monetization. Over the next 1-3 months, watch for guidance on operating expense growth and customer expansion; if costs are still ramping while revenue acceleration remains flat, the stock could de-rate on execution concerns. Over 6-18 months, the thesis is falsified if AI features do not improve retention or ARPU, or if competitors replicate the workflow quickly enough to keep the platform from becoming differentiated.

Key Decisions for Investors

• No immediate directional trade in SONG; wait for 1Q26/2Q26 proof points on retention, ARPU, and gross margin before underwriting the AI platform thesis.
• Set a watch item on SONG: if management quantifies accelerating customer growth with stable opex growth, consider a small starter long; if opex grows faster than revenue for two quarters, avoid or fade rallies.
• Relative-value idea: long SONG / short SSTK only if SONG shows measurable workflow adoption and SSTK continues to face pricing pressure from AI-generated content substitution.
• Use GETY and SSTK as read-through shorts on any evidence that AI-enabled content creation is compressing licensing economics; this is a 3-6 month catalyst, not a one-day trade.
• Falsifier alert: if SONG’s next update shows no improvement in net revenue retention or gross margin despite heavier 2025 investment, the market is likely to treat the AI narrative as non-monetizable.